Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
The Prostate|June 25, 2016
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN StudyMichael T Schweizer, Hao Wang, Brandon Luber, et al.
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Oncotarget|May 12, 2017
Mesenchymal stem cell infiltration during neoplastic transformation of the human prostateW Nathaniel Brennen, Baohui Zhang, Ibrahim Kulac, et al.
The Prostate|April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancerCatherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
The Prostate|April 8, 2026
Castration Resistance Accelerates Prostate Cancer KineticsSheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
The Prostate|January 3, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical StudyEzra G Baraban, Evangelia Vlachou, Sunil Patel, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptorRajendra Kumar, Janet Mendonca, Abhishek Shetty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptorRajendra Kumar, Janet Mendonca, Abhishek Shetty, et al.
European Urology|October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene DefectsPedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.
The Prostate|August 10, 2023
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancerJohn T Isaacs, Susan L Dalrymple, Lizamma Antony, et al.
Pageof 23